US$ 22.45
bpc 157 im or subq BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA bpc 157 im or subq
Description
L-Carnitine Supports healthy metabolism
At loading doses of 5 mg per week, one vial lasts one week

the B12 supports energy levels during caloric deficit but does not change tirzepatide's pharmacology

Some possible complications include bleeding, infection, and nerve damage
